FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Published Aug 29, 2020

FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Foundation Medicine just got the green light from the Food and Drug Administration (FDA) to launch a new blood test which could eliminate the fuss of additional biopsies and determine treatment faster.

NOW
PLAYING
Non-Hodgkin Lymphoma: Can Radiation Scans Cause Cancer?
NOW
PLAYING
New Drug Selinexor (Xpovio) Has Many Risks, Limited Benefits Against Non-Hodgkin Lymphoma
NOW
PLAYING
What Kind of Biopsy Do You Need?
NOW
PLAYING
Blood Test Could Help Choose Melanoma Treatment
NOW
PLAYING
Blood Tests for Early Cancer Detection—Will the New Multi-Billion Dollar Deals Actually Help Save Lives?
NOW
PLAYING
As the Government Goes After Google for Antitrust Violations, What Does it Mean For Cancer Patients Who Need Reliable Information?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.